Considering Mutations and Resistance in Lung Cancer to Improve Precision Medicine
January 21st 2021Anne Chiang, MD, associate professor, Medical Oncology, Yale School of Medicine, discusses hard-to-treat lung cancer and how due to recent lung cancer innovations and treatment options, the tumor is becoming increasingly heterogeneous.